We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CANO
4701
DELISTED
Cano Health, Inc.
CANO
$973K ﹤0.01%
+804
New +$1.08M
PICC
4702
DELISTED
Pivotal Investment Corporation III
PICC
$971K ﹤0.01%
+99,550
New +$978K
OLK
4703
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$969K ﹤0.01%
28,163
+3,163
+13% +$109K
VGII.U
4704
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$968K ﹤0.01%
+96,596
New +$968K
STRO icon
4705
Sutro Biopharma
STRO
$409M
$967K ﹤0.01%
5,201
-2,138
-29% -$418K
SKIN icon
4706
SkinHealth Systems
SKIN
$92.2M
$966K ﹤0.01%
+57,497
New +$786K
TG icon
4707
Tredegar Corp
TG
$266M
$964K ﹤0.01%
69,944
+22,280
+47% +$335K
BFS
4708
Saul Centers
BFS
$837M
$961K ﹤0.01%
21,145
-9,038
-30% -$392K
SMBK icon
4709
SmartFinancial
SMBK
$904M
$961K ﹤0.01%
40,028
-2,008
-5% -$47.3K
EXFO
4710
DELISTED
EXFO INC.
EXFO
$960K ﹤0.01%
161,409
BHB icon
4711
Bar Harbor Bankshares
BHB
$674M
$959K ﹤0.01%
+33,492
New +$987K
IVR icon
4712
Invesco Mortgage Capital
IVR
$760M
$958K ﹤0.01%
24,566
-41,565
-63% -$1.57M
KROS icon
4713
Keros Therapeutics
KROS
$198M
$954K ﹤0.01%
22,470
+16,108
+253% +$873K
DMTK
4714
DELISTED
DermTech, Inc. Common Stock
DMTK
$954K ﹤0.01%
22,962
+6,275
+38% +$258K
CSX icon
4715
PUT
CSX Corp
CSX
$92.9B
$953K ﹤0.01%
29,700
-7,200
-20% -$237K
PLL
4716
DELISTED
Piedmont Lithium
PLL
$951K ﹤0.01%
+12,167
New +$825K
TKC icon
4717
Turkcell
TKC
$4.82B
$951K ﹤0.01%
203,665
+3,798
+2% +$17.8K
BNT
4718
Brookfield Wealth Solutions
BNT
$11.9B
$951K ﹤0.01%
+27,431
New +$1.04M
PNTM.U
4719
DELISTED
Pontem Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
PNTM.U
$951K ﹤0.01%
95,001
-83,175
-47% -$832K
WPCB
4720
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$951K ﹤0.01%
+97,450
New +$960K
PDOT
4721
DELISTED
Peridot Acquisition Corp. II
PDOT
$949K ﹤0.01%
+97,695
New +$953K
JCICU
4722
DELISTED
Jack Creek Investment Corp. Units
JCICU
$948K ﹤0.01%
94,301
-33,412
-26% -$335K
SGFY
4723
DELISTED
Signify Health, Inc.
SGFY
$947K ﹤0.01%
31,117
+7,067
+29% +$194K
MBWM icon
4724
Mercantile Bank Corp
MBWM
$1.05B
$946K ﹤0.01%
31,313
+6,514
+26% +$208K
KCE icon
4725
State Street SPDR S&P Capital Markets ETF
KCE
$463M
$944K ﹤0.01%
+10,034
New +$911K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.